Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.9.3997

Human Papillomavirus Genotype Distribution and E6/E7 Oncogene Expression in Turkish Women with Cervical Cytological Findings  

Tezcan, Seda (Department of Medical Microbiology, Faculty of Medicine, Mersin University)
Ozgur, Didem (Department of Medical Microbiology, Faculty of Medicine, Mersin University)
Ulger, Mahmut (Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University)
Aslan, Gonul (Department of Medical Microbiology, Faculty of Medicine, Mersin University)
Gurses, Iclal (Department of Pathology, Faculty of Medicine, Mersin University)
Serin, Mehmet Sami (Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Mersin University)
Giray, Burcu Gurer (Department of Medical Microbiology, Faculty of Medicine, Mersin University)
Dilek, Saffet (Department of Obstetric and Gynecology, Faculty of Medicine, Mersin University)
Emekdas, Gurol (Department of Medical Microbiology, Faculty of Medicine, Mersin University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.9, 2014 , pp. 3997-4003 More about this Journal
Abstract
Background: Infection with certain human papillomavirus (HPV) genotypes is the most important risk factor related with cervical cancer. The objective of the present study was to investigate the prevalence of HPV infection, the distribution of HPV genotypes and HPV E6/E7 oncogene mRNA expression in Turkish women with different cervical cytological findings in Mersin province, Southern Turkey. Materials and Methods: A total of 476 cytological samples belonging to women with normal and abnormal cervical Pap smears were enrolled in the study. For the detection and genotyping assay, a PCR/direct cycle sequencing approach was used. E6/E7 mRNA expression of HPV-16, 18, 31, 33, and 45 was determined by type-specific real-time NASBA assay (NucliSENS EasyQ$^{(R)}$HPV v1.1). Results: Of the 476 samples, 106 (22.3%) were found to be positive for HPV DNA by PCR. The presence of HPV was significantly more common (p<0.001) in HSIL (6/8, 75%) when compared with LSIL (6/14, 42.9%), ASC-US (22/74, 29.7%) and normal cytology (72/380, 18.9%). The most prevalent genotypes were, in descending order of frequency, HPV genotype 66 (22.6%), 16 (20.8%), 6 (14.2%), 31 (11.3%), 53 (5.7%), and 83 (4.7%). HPV E6/E7 oncogene mRNA positivity (12/476, 2.5%) was lower than DNA positivity (38/476, 7.9%). Conclusions: Our data present a wide distribution of HPV genotypes in the analyzed population. HPV genotypes 66, 16, 6, 31, 53 and 83 were the predominant types and most of them were potential carcinogenic types. Because of the differences between HPV E6/E7 mRNA and DNA positivity, further studies are required to test the role of mRNA testing in the triage of women with abnormal cervical cytology or follow up of HPV DNA positive and cytology negative. These epidemiological data will be important to determine the future impact of vaccination on HPV infected women in our region.
Keywords
Human papillomavirus; consensus PCR; cycle sequencing; E6/E7 mRNA; genotype; Turkish women;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2014). Distribution of HPV genotypes in cervical cancer in multi- ethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6.   과학기술학회마을   DOI   ScienceOn
2 Giorgi Rossi P, Benevolo M, Vocaturo A, et al (2013). Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study. PLoS One, 8, 57600.   DOI
3 Guan P, Howell-Jones R, Li N, et al (2012). Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer, 131, 2349-59.   DOI   ScienceOn
4 Jastreboff AM, Cymet T (2002). Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J, 78, 225-8.   DOI
5 Jeantet D, Schwarzmann F, Tromp J, et al (2009). NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses. J Clin Virol, 45, 29-37.   DOI   ScienceOn
6 Kitchener HC, Denton K, Soldan K, Crosbie EJ (2013). Developing role of HPV in cervical cancer prevention. BMJ, 347, 4781.   DOI
7 Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer, 128, 927-35.   DOI   ScienceOn
8 Lin CY, Chen HC, Lin RW, et al (2007). Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods, 140, 1-9.   DOI   ScienceOn
9 Lin CY, Chao A, Yang YC, et al (2008). Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol, 42, 361-7.   DOI   ScienceOn
10 Coutlee F, Rouleau D, Ferenczy A, Franco E (2005). The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol, 16, 83-91.
11 Bosch FX, Broker TR, Forman D, et al (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine, 31, 1-31.   DOI
12 Dursun P, Ayhan A, Mutlu L, et al (2013). HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg, 29, 210-6.
13 Chen Q, Luo ZY, Lin M, et al (2012). Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province. Asian Pac J Cancer Prev, 13, 1519-24.   과학기술학회마을   DOI   ScienceOn
14 Ciesielska U, Nowi.ska K, Podhorska-Okolow M, Dziegiel P (2012). The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus. Adv Clin Exp Med, 21, 235-44.
15 Doorbar J, Quint W, Banks L, et al (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30, 55-70.   DOI   ScienceOn
16 Ergunay K, Misirlioglu M, Firat P, et al (2008). Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities. Mikrobiyol Bul, 42, 273-82.
17 Evander M, Edlund K, Gustafsson A, et al (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis, 171, 1026-30.   DOI   ScienceOn
18 Gibb RK, Martens MG (2011). The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol, 4, 2-11.
19 Abike F, Bingol B, Yilmaz A, et al (2013). HPV Infection and HPV Subtypes in Normal and Abnormal Cervical Cytology in Turkish Women. J Virology & Microbiology, 640873.
20 Batmaz G, Cetin A, Dane C, Gorgen H, Dane B (2009). HPV DNA positivity in women with normal and abnormal cervical smears. Turk J Gynecol Oncol, 1, 10-4.
21 Benevolo M, Terrenato I, Mottolese M, et al (2011). Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients. Cancer Causes Control, 22, 869-75.   DOI
22 Spathis A, Kottaridi C, Chranioti A, et al (2012). mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One, 7, 49205.   DOI
23 Speich N, Schmitt C, Bollmann R, Bollmann M (2004). Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol, 53, 125-8.   DOI   ScienceOn
24 Schiffman M, Herrero R, Desalle R, et al (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology, 337, 76-84.   DOI   ScienceOn
25 Snijders PJ, van den Brule AJ, Schrijnemakers HF, et al (1990). The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol, 71, 173-81.   DOI   ScienceOn
26 Turki R, Sait K, Anfinan N, Sohrab SS, Abuzenadah AM (2013). Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev, 14, 3177-81.   과학기술학회마을   DOI   ScienceOn
27 Munoz N, Bosch FX, Castellsague X, et al (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 111, 278-85.   DOI   ScienceOn
28 Villa LL, Denny L (2006). Methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet, 94, 71-80.   DOI   ScienceOn
29 Wang L, Dai SZ, Chu HJ, Cui HF, Xu XY (2013). Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev, 14, 3837-41.   과학기술학회마을   DOI   ScienceOn
30 Yildirim D, Yildirim ME, Bakici MZ (2013). Human papillomavirus positivity and frequency of genotypes in servical samples of women living in Sivas Region. Firat Med J, 18, 94-97.
31 Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989). The use of polymerase reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209-14.
32 Meijer CJ, Snijders PJ, Castle PE (2006). Clinical utility of HPV genotyping. Gynecol Oncol, 103, 12-7.   DOI   ScienceOn
33 Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.   DOI   ScienceOn
34 Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northest Thailand. Asian Pac J Cancer Prev, 14, 6961-4.   과학기술학회마을   DOI   ScienceOn
35 Ozturk S, Kaleli I, Kaleli B, Bir F (2004). Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay. Mikrobiyol Bul, 38, 223-32.
36 Shen-Gunther J, Yu X (2011). HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens. Gynecol Oncol, 123, 263-71.   DOI   ScienceOn
37 Pannier-Stockman C, Segard C, Bennamar S, et al (2008). Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol, 42, 353-60.   DOI   ScienceOn
38 Ronco G, Giorgi Rossi P (2008). New paradigms in cervical cancer prevention: opportunities and risks. BMC Womens Health, 8, 23.   DOI   ScienceOn
39 Sahiner F, Kubar A, Yapar M, et al (2014). Detection of major HPVs by a new multiplex real-time PCR assay using type-specific primers. J Microbiol Methods, 97, 44-50.   DOI   ScienceOn
40 Yuce K, Pinar A, Salman MC, et al (2012). Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study. Arch Gynecol Obstet, 286, 203-8.   DOI
41 Akcali S, Goker A, Ecemis T, Kandiloglu AR, Sanlidag T (2013). Human papilloma virus frequency and genotype distribution in a Turkish population. Asian Pac J Cancer Prev, 14, 503-6.   과학기술학회마을   DOI   ScienceOn